The federal contract IDV award SPE2DB24D2012 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) and prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $999,999,999.00 IDC has a period of performance through December 31, 2025 and serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. Firm fixed price task orders issued under this IDC have enabled the provision of a comprehensive range of medications and healthcare materials, including specialty, brand name, generic, and over-the-counter pharmaceuticals as well as critical care supplies such as syringes, vials, and test kits. No set-aside designations have been used for this contract. The IDC does not fall under any overarching contract vehicles and was awarded solely to Amerisourcebergen Drug Corp.
Amerisourcebergen Drug Corp, through its Corporate Office division, has a long history of providing pharmaceutical and medical supply products and services to various U.S. government agencies, primarily the Department of Defense. In addition to the DLA Troop Support Medical IDC, Amerisourcebergen Drug Corp holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, valued at up to $750,000 through May 2024.
Generated 6/10/24, 9:05 AM